C
Corona Remedies Ltd
PharmaceuticalsSmallcap
About the company
Corona Remedies Ltd develops, manufactures, and markets pharmaceutical formulations in women’s healthcare, cardio-diabetes, pain management, urology, and multispecialty areas with multiple dosage forms and approximately 67 brands.
Performance
- Stock
- Loading Stock value
—
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 65.13 | 34.78 |
| PB Ratio | 16.05 | 5.49 |
| Dividend Yield | 0.46% | 0.61% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions